BE2015C067I2 - - Google Patents

Info

Publication number: BE2015C067I2
Authority: BE; Belgium

Application number

BE2015C067C

Original Assignee

Glaxosmithkline Biologicals Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-12-20

Filing date

2015-12-09

Publication date

2024-08-08

2015-12-09 Application filed by Glaxosmithkline Biologicals Sa filed Critical Glaxosmithkline Biologicals Sa

2024-08-08 Publication of BE2015C067I2 publication Critical patent/BE2015C067I2/fr

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Virology (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Biochemistry (AREA)
Immunology (AREA)
Microbiology (AREA)
Wood Science & Technology (AREA)
Gastroenterology & Hepatology (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Biomedical Technology (AREA)
General Engineering & Computer Science (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Mycology (AREA)
Epidemiology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

BE2015C067C 2002-12-20 2015-12-09 BE2015C067I2 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US43503502P	2002-12-20	2002-12-20
US49665303P	2003-08-20	2003-08-20

Publications (1)

Publication Number	Publication Date
BE2015C067I2 true BE2015C067I2 (fr)	2024-08-08

Family

ID=32685362

Family Applications (3)

Application Number	Title	Priority Date
BE2015C068C BE2015C068I2 (fr)	2002-12-20	2015-12-09
BE2015C069C BE2015C069I2 (fr)	2002-12-20	2015-12-09
BE2015C067C BE2015C067I2 (fr)	2002-12-20	2015-12-09

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
BE2015C068C BE2015C068I2 (fr)	2002-12-20	2015-12-09
BE2015C069C BE2015C069I2 (fr)	2002-12-20	2015-12-09

Country Status (28)

Country	Link
US (2)	US20060251676A1 (fr)
EP (1)	EP1572233B1 (fr)
JP (1)	JP5475939B2 (fr)
KR (3)	KR101361769B1 (fr)
AP (1)	AP2005003347A0 (fr)
AR (1)	AR042530A1 (fr)
AT (1)	ATE503492T1 (fr)
AU (1)	AU2003293942B2 (fr)
BE (3)	BE2015C068I2 (fr)
BR (1)	BR0317544A (fr)
CA (1)	CA2510457C (fr)
CY (1)	CY1111552T1 (fr)
DE (1)	DE60336581D1 (fr)
DK (1)	DK1572233T3 (fr)
EA (2)	EA009179B1 (fr)
EC (1)	ECSP055869A (fr)
IL (1)	IL169085A (fr)
IS (1)	IS2811B (fr)
MA (1)	MA27581A1 (fr)
MX (1)	MXPA05006764A (fr)
MY (1)	MY144492A (fr)
NO (1)	NO20052846L (fr)
NZ (1)	NZ540811A (fr)
OA (1)	OA13147A (fr)
PL (1)	PL215257B1 (fr)
PT (1)	PT1572233E (fr)
TW (1)	TWI349557B (fr)
WO (1)	WO2004056389A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2003519084A (ja)	1998-10-16	2003-06-17	グラクソスミスクラインバイオロジカルズソシエテアノニム	ワクチン
GB0206360D0 (en)	2002-03-18	2002-05-01	Glaxosmithkline Biolog Sa	Viral antigens
US7858098B2 (en)	2002-12-20	2010-12-28	Glaxosmithkline Biologicals, S.A.	Vaccine
US7758866B2 (en) *	2004-06-16	2010-07-20	Glaxosmithkline Biologicals, S.A.	Vaccine against HPV16 and HPV18 and at least another HPV type selected from HPV 31, 45 or 52
PL1758609T3 (pl) *	2004-06-16	2013-02-28	Glaxosmithkline Biologicals Sa	Szczepionka przeciw HPV16 i HPV18 oraz co najmniej jednemu HPV innego typu wybranemu spośród HPV 31, 45 lub 52
CA2604909A1 (fr)	2005-04-15	2006-10-26	The Government Of The United States Of America, As Represented By The Se Cretary, Department Of Health And Human Services	Procedes et compositions permettant de produire une reponse immunitaire amelioree contre un immunogene papillomavirus humain
EA013326B1 (ru) *	2005-04-26	2010-04-30	Глаксосмитклайн Байолоджикалс С.А.	Вакцина
AR053715A1 (es) *	2005-04-26	2007-05-16	Glaxosmithkline Biolog Sa	Vacuna multivalente de vph
DK2154147T3 (en) *	2007-04-29	2015-12-07	Beijing Wantai Biological Pharmacy Entpr Co Ltd	Truncated L1 protein of human papillomavirus 16
EP2147926B1 (fr)	2007-04-29	2016-08-24	Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.	Protéines 18 l1 de type papillomavirus humain tronque
US20120058149A1 (en) *	2009-03-05	2012-03-08	Mccloskey Jenny Colleen	Treatment of infection
MX2011013566A (es) *	2009-06-19	2012-06-28	Eyegene Inc	Vacunas para cancer cervical.
WO2015114506A2 (fr)	2014-01-31	2015-08-06	Marini Bruna	Biocapteur pour la détermination d'infections et de pathologies associées
US10799574B2 (en)	2014-10-24	2020-10-13	Hpvvax. Llc	Method and composition for treating cancer or skin lesion using a vaccine
AU2015335652B2 (en)	2014-10-24	2020-07-02	Hpvvax, Llc.	Cancer and skin lesion treatment
RU2721417C2 (ru) *	2015-06-02	2020-05-19	Терумо Кабусики Кайся	Адъювантная композиция, содержащая алюминий, и содержащая ее вакцинная композиция
JP7581048B2 (ja) *	2018-03-06	2024-11-12	プレシゲン，インコーポレイテッド	ヒトパピローマウイルスワクチンおよびその使用
IL277128B2 (en)	2018-03-06	2025-11-01	Precigen Inc	Hepatitis b vaccines and uses of the same
US11771754B2 (en) *	2018-06-04	2023-10-03	Xiamen University	Mutant of L1 protein of human papillomavirus type 18
JP7558167B2 (ja)	2018-12-03	2024-09-30	ボードオブリージェンツ，ザユニバーシティオブテキサスシステム	オリゴベンズアミド類似体およびがん処置におけるそれらの使用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4332596A1 (de) *	1993-09-24	1995-03-30	Martin Josef Dr Sapp	Monoklonale Antikörper
DE69835294T2 (de)	1997-09-05	2007-07-26	Medimmune, Inc.	Methode zur in vitro auseinander- und wiederzusammensetzung von papillomavirus virusähnlichen teilchen (vlps)
PT1150712E (pt) *	1999-02-05	2008-12-22	Merck & Co Inc	Formulações para a vacina do vírus do papiloma humano
US6245568B1 (en)	1999-03-26	2001-06-12	Merck & Co., Inc.	Human papilloma virus vaccine with disassembled and reassembled virus-like particles
GB9921146D0 (en) *	1999-09-07	1999-11-10	Smithkline Beecham Biolog	Novel composition
US6908613B2 (en) *	2000-06-21	2005-06-21	Medimmune, Inc.	Chimeric human papillomavirus (HPV) L1 molecules and uses therefor
PL359930A1 (en) *	2000-06-26	2004-09-06	Stressgen Biotechnologies Corporation	Human papilloma virus treatment

2003
- 2003-12-18 OA OA1200500189A patent/OA13147A/en unknown
- 2003-12-18 NZ NZ540811A patent/NZ540811A/en not_active IP Right Cessation
- 2003-12-18 JP JP2005502554A patent/JP5475939B2/ja not_active Expired - Lifetime
- 2003-12-18 DK DK03789346.8T patent/DK1572233T3/da active
- 2003-12-18 PL PL377710A patent/PL215257B1/pl unknown
- 2003-12-18 WO PCT/EP2003/014562 patent/WO2004056389A1/fr not_active Ceased
- 2003-12-18 DE DE60336581T patent/DE60336581D1/de not_active Expired - Lifetime
- 2003-12-18 MY MYPI20034868A patent/MY144492A/en unknown
- 2003-12-18 TW TW092135963A patent/TWI349557B/zh not_active IP Right Cessation
- 2003-12-18 AR ARP030104709A patent/AR042530A1/es unknown
- 2003-12-18 AU AU2003293942A patent/AU2003293942B2/en not_active Expired
- 2003-12-18 EA EA200500834A patent/EA009179B1/ru not_active IP Right Cessation
- 2003-12-18 EA EA200701633A patent/EA200701633A1/ru unknown
- 2003-12-18 CA CA2510457A patent/CA2510457C/fr not_active Expired - Lifetime
- 2003-12-18 KR KR1020127027784A patent/KR101361769B1/ko not_active Expired - Lifetime
- 2003-12-18 BR BR0317544-8A patent/BR0317544A/pt not_active Application Discontinuation
- 2003-12-18 AP AP2005003347A patent/AP2005003347A0/xx unknown
- 2003-12-18 US US10/540,099 patent/US20060251676A1/en not_active Abandoned
- 2003-12-18 PT PT03789346T patent/PT1572233E/pt unknown
- 2003-12-18 KR KR1020127026719A patent/KR20120118087A/ko not_active Withdrawn
- 2003-12-18 AT AT03789346T patent/ATE503492T1/de active
- 2003-12-18 KR KR1020057011497A patent/KR20050086924A/ko not_active Ceased
- 2003-12-18 MX MXPA05006764A patent/MXPA05006764A/es active IP Right Grant
- 2003-12-18 EP EP03789346A patent/EP1572233B1/fr not_active Expired - Lifetime
2005
- 2005-04-26 US US11/114,301 patent/US20050287161A1/en not_active Abandoned
- 2005-06-09 IL IL169085A patent/IL169085A/en active IP Right Grant
- 2005-06-09 IS IS7885A patent/IS2811B/is unknown
- 2005-06-13 NO NO20052846A patent/NO20052846L/no not_active Application Discontinuation
- 2005-06-20 EC EC2005005869A patent/ECSP055869A/es unknown
- 2005-07-18 MA MA28398A patent/MA27581A1/fr unknown
2011
- 2011-06-08 CY CY20111100549T patent/CY1111552T1/el unknown
2015
- 2015-12-09 BE BE2015C068C patent/BE2015C068I2/fr unknown
- 2015-12-09 BE BE2015C069C patent/BE2015C069I2/fr unknown
- 2015-12-09 BE BE2015C067C patent/BE2015C067I2/fr unknown

Also Published As

Publication number	Publication date
BR0317544A (pt)	2005-11-22
JP5475939B2 (ja)	2014-04-16
EA200500834A1 (ru)	2006-02-24
DK1572233T3 (da)	2011-06-27
PT1572233E (pt)	2011-06-07
CA2510457A1 (fr)	2004-07-08
IL169085A (en)	2014-04-30
WO2004056389A1 (fr)	2004-07-08
KR20120118087A (ko)	2012-10-25
TWI349557B (en)	2011-10-01
IS2811B (is)	2012-11-15
JP2006512413A (ja)	2006-04-13
IS7885A (is)	2005-06-09
KR20050086924A (ko)	2005-08-30
OA13147A (en)	2006-12-13
KR20120123616A (ko)	2012-11-08
AP2005003347A0 (en)	2005-06-30
CA2510457C (fr)	2011-12-06
MXPA05006764A (es)	2005-09-08
ECSP055869A (es)	2005-09-20
EA200701633A1 (ru)	2007-12-28
TW200423957A (en)	2004-11-16
US20060251676A1 (en)	2006-11-09
IL169085A0 (en)	2007-07-04
PL215257B1 (pl)	2013-11-29
AR042530A1 (es)	2005-06-22
EP1572233A1 (fr)	2005-09-14
US20050287161A1 (en)	2005-12-29
BE2015C069I2 (fr)	2024-08-08
NZ540811A (en)	2007-03-30
BE2015C068I2 (fr)	2024-08-08
AU2003293942A1 (en)	2004-07-14
AU2003293942B2 (en)	2009-12-10
NO20052846L (no)	2005-07-13
PL377710A1 (pl)	2006-02-06
DE60336581D1 (de)	2011-05-12
EA009179B1 (ru)	2007-12-28
KR101361769B1 (ko)	2014-02-10
MA27581A1 (fr)	2005-10-03
ATE503492T1 (de)	2011-04-15
MY144492A (en)	2011-09-30
HK1085378A1 (en)	2006-08-25
EP1572233B1 (fr)	2011-03-30
CY1111552T1 (el)	2015-08-05

Publication	Publication Date	Title
BE2019C547I2 (fr)	2022-05-17
BE2014C051I2 (fr)	2022-08-09
BE2014C041I2 (fr)	2022-08-09
FR14C0045I1 (fr)	2014-07-18
BE2014C030I2 (fr)	2022-08-09
BE2014C016I2 (fr)	2023-03-07
BE2013C063I2 (fr)	2023-03-07
BE2013C039I2 (fr)	2023-03-07
BE2011C038I2 (fr)	2022-08-09
JP2003179670A5 (fr)	2005-10-27
JP2003110999A5 (fr)	2005-10-27
BE2015C067I2 (fr)	2024-08-08
BRPI0215435A2 (fr)	2004-12-14
JP2003162975A5 (fr)	2005-12-02
BE2013C046I2 (fr)	2022-08-09
JP2003198851A5 (fr)	2005-11-04
JP2003072981A5 (fr)	2005-10-27
HU0201760D0 (fr)	2002-07-29
JP2003154580A5 (fr)	2005-10-27
JP2003083289A5 (fr)	2005-09-22
JP2003237285A5 (fr)	2005-10-13
JP2003207005A5 (fr)	2005-06-30
JP2003223425A5 (fr)	2006-11-16
BR0315835A2 (fr)	2009-01-20
JP2003240594A5 (fr)	2005-08-04